233 related articles for article (PubMed ID: 32003121)
1. Inhibiting MARSs reduces hyperhomocysteinemia-associated neural tube and congenital heart defects.
Mei X; Qi D; Zhang T; Zhao Y; Jin L; Hou J; Wang J; Lin Y; Xue Y; Zhu P; Liu Z; Huang L; Nie J; Si W; Ma J; Ye J; Finnell RH; Saiyin H; Wang H; Zhao J; Zhao S; Xu W
EMBO Mol Med; 2020 Mar; 12(3):e9469. PubMed ID: 32003121
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against homocysteinylated protein in a mouse model of folate deficiency-induced neural tube defects.
Denny KJ; Kelly CF; Kumar V; Witham KL; Cabrera RM; Finnell RH; Taylor SM; Jeanes A; Woodruff TM
Birth Defects Res A Clin Mol Teratol; 2016 Mar; 106(3):201-7. PubMed ID: 26900104
[TBL] [Abstract][Full Text] [Related]
3. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
Jakubowski H
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
[TBL] [Abstract][Full Text] [Related]
4. The application of a chemical determination of N-homocysteinylation levels in developing mouse embryos: implication for folate responsive birth defects.
Fathe K; Person MD; Finnell RH
J Nutr Biochem; 2015 Apr; 26(4):312-8. PubMed ID: 25620692
[TBL] [Abstract][Full Text] [Related]
5. [THE DIFFERENTIATED APPROACH TO PREVENTION OF NEURAL TUBE DEFECTS IN CHILDREN].
Kotova N; Maichuk V; Fedorenko O
Georgian Med News; 2018 Jan; (274):52-59. PubMed ID: 29461227
[TBL] [Abstract][Full Text] [Related]
6. Protein homocysteinylation: a new mechanism of atherogenesis?
Bełtowski J
Postepy Hig Med Dosw (Online); 2005; 59():392-404. PubMed ID: 16106241
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine and folic acid: implications for pregnancy.
Daly S; Cotter A; Molloy AE; Scott J
Semin Vasc Med; 2005 May; 5(2):190-200. PubMed ID: 16047271
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocysteinemia in men with a reproductive history of fetal neural tube defects: Three case reports and literature review.
Yu Y; Jia C; Shi Q; Zhu Y; Liu Y
Medicine (Baltimore); 2019 Jan; 98(2):e13998. PubMed ID: 30633186
[TBL] [Abstract][Full Text] [Related]
9. High Homocysteine-Thiolactone Leads to Reduced MENIN Protein Expression and an Impaired DNA Damage Response: Implications for Neural Tube Defects.
Bai B; Wan C; Xiao Z; Li D; Liu L; Zhang K; Zhang T; Zhang Q
Mol Neurobiol; 2024 Feb; ():. PubMed ID: 38386135
[TBL] [Abstract][Full Text] [Related]
10. [Homocysteine and hyperhomocysteinemia].
Laskowska-Klita T
Pol Merkur Lekarski; 2001 Mar; 10(57):135-7. PubMed ID: 11398509
[TBL] [Abstract][Full Text] [Related]
11. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects.
Blom HJ; Smulders Y
J Inherit Metab Dis; 2011 Feb; 34(1):75-81. PubMed ID: 20814827
[TBL] [Abstract][Full Text] [Related]
12. N-homocysteinylation of tau and MAP1 is increased in autopsy specimens of Alzheimer's disease and vascular dementia.
Bossenmeyer-Pourié C; Smith AD; Lehmann S; Deramecourt V; Sablonnière B; Camadro JM; Pourié G; Kerek R; Helle D; Umoret R; Guéant-Rodriguez RM; Rigau V; Gabelle A; Sequeira JM; Quadros EV; Daval JL; Guéant JL
J Pathol; 2019 Jul; 248(3):291-303. PubMed ID: 30734924
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic alterations in folate transport genes in placental tissue from fetuses with neural tube defects and in leukocytes from subjects with hyperhomocysteinemia.
Farkas SA; Böttiger AK; Isaksson HS; Finnell RH; Ren A; Nilsson TK
Epigenetics; 2013 Mar; 8(3):303-16. PubMed ID: 23417011
[TBL] [Abstract][Full Text] [Related]
14. [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].
Guilland JC; Favier A; Potier de Courcy G; Galan P; Hercberg S
Pathol Biol (Paris); 2003 Mar; 51(2):101-10. PubMed ID: 12801808
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia: related genetic diseases and congenital defects, abnormal DNA methylation and newborn screening issues.
Iacobazzi V; Infantino V; Castegna A; Andria G
Mol Genet Metab; 2014; 113(1-2):27-33. PubMed ID: 25087163
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological consequences of homocysteine excess.
Jakubowski H
J Nutr; 2006 Jun; 136(6 Suppl):1741S-1749S. PubMed ID: 16702349
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of Epigenetic Mechanisms of Gene Expression in the Pathologies of Hyperhomocysteinemia.
Perła-Kaján J; Jakubowski H
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31252610
[TBL] [Abstract][Full Text] [Related]
18. Open or closed? A world of difference: a history of homocysteine research.
Eskes TK
Nutr Rev; 1998 Aug; 56(8):236-44. PubMed ID: 9735677
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Protein N-Homocysteinylation in Rat Plasma under Elevated Homocysteine Using a Specific Chemical Labeling Method.
Zang T; Pottenplackel LP; Handy DE; Loscalzo J; Dai S; Deth RC; Zhou ZS; Ma J
Molecules; 2016 Sep; 21(9):. PubMed ID: 27617989
[TBL] [Abstract][Full Text] [Related]
20. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects?
Steegers-Theunissen RP; Boers GH; Trijbels FJ; Finkelstein JD; Blom HJ; Thomas CM; Borm GF; Wouters MG; Eskes TK
Metabolism; 1994 Dec; 43(12):1475-80. PubMed ID: 7990699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
